Sellas Life Sciences Group Inc SLS shares are trading lower by 35.7% to $0.58 Thursday afternoon. The stock is trading lower after the company announced pricing of a $9 million public offering.
What Else?
The 12 million shares of common stock along with accompanying warrants aims to generate $9 million before expenses.
Priced at $0.75 per share and warrant, these securities will grant the option to purchase an equal number of shares at the same price within five years.
A.G.P./Alliance Global Partners is the exclusive placement agent for this offering, set to conclude around January 8, pending standard closing conditions.
See Also: December Jobs Report Preview
According to data from Benzinga Pro, SLS has a 52-week high of $4.13 and a 52-week low of $0.58.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
